Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years

Title
Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years
Authors
Keywords
Diabetes mellitus, Health services for the aged, Hepatitis B, Hepatitis B vaccines, Vaccination, Advisory Committee on Immunization Practices
Journal
VACCINE
Volume 37, Issue 39, Pages 5854-5861
Publisher
Elsevier BV
Online
2019-08-18
DOI
10.1016/j.vaccine.2019.08.005

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now